According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is $4.39. In 2022 the company made an earnings per share (EPS) of $3.67 a decrease over its 2021 EPS that were of $4.95.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $4.39 | 19.62% |
2022 | $3.67 | -25.86% |
2021 | $4.95 | 4850% |
2020 | $0.10000 | -97.64% |
2019 | $4.24 | 0.9% |
2018 | $4.20 | 18.71% |
2017 | $3.54 | -64.88% |
2016 | $10.08 | -18.45% |
2015 | $12.36 | 55.28% |
2014 | $7.96 | 296.02% |
2013 | $2.01 | 17.89% |
2012 | $1.70 | -6.32% |
2011 | $1.82 | 7.69% |
2010 | $1.69 | 15.75% |
2009 | $1.46 | 36.45% |
2008 | $1.07 | 22.99% |
2007 | $0.87 | -233.33% |
2006 | -$0.65 | -246.63% |
2005 | $0.44 | 71.15% |
2004 | $0.26 | -633.33% |
2003 | -$0.04875 | -205.41% |
2002 | $0.04625 | 29.82% |
2001 | $0.03562 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $14.09 | 220.85% | ๐บ๐ธ USA |
Pfizer PFE | $1.86 | -57.63% | ๐บ๐ธ USA |
AbbVie ABBV | $3.68 | -16.16% | ๐บ๐ธ USA |
Eli Lilly LLY | $5.43 | 23.67% | ๐บ๐ธ USA |
Amgen AMGN | $14.15 | 222.32% | ๐บ๐ธ USA |
Biogen BIIB | $18.46 | 320.50% | ๐บ๐ธ USA |
Illumina ILMN | -$26.61 | -706.15% | ๐บ๐ธ USA |
Vertex Pharmaceuticals VRTX | $13.09 | 198.18% | ๐บ๐ธ USA |
Merck MRK | $1.82 | -58.50% | ๐บ๐ธ USA |